Fluoroscopy and C - Arms Market Size, Share, and Growth Forecast, 2026 – 2033

The global fluoroscopy and C - arms market size is likely to be valued at US$3.2 billion in 2026 and is expected to reach US$4.4 billion by 2033, growing at a CAGR of 4.8% during the forecast period from 2026 to 2033, driven by the growing need for real-time imaging during minimally invasive and image-guided procedures across orthopedics, cardiology, vascular care, pain management, and oncology.

In 2025, the WHO reported that noncommunicable diseases caused at least 43 million deaths in 2021, with cardiovascular diseases accounting for at least 19 million deaths, strengthening demand for diagnostic and interventional imaging technologies.

Driver - Rising Adoption of Minimally Invasive and Image-Guided Procedures

Fluoroscopy and C-arms are benefiting from the continued shift toward minimally invasive procedures that require real-time visualization during interventions. Hospitals increasingly use these systems in orthopedic surgery, trauma care, cardiovascular interventions, pain management, and interventional radiology. C-arms provide continuous imaging without requiring patients to be moved between procedure rooms, supporting procedural accuracy and workflow efficiency.

Growing preference for shorter hospital stays and faster recovery is also encouraging clinicians to adopt image-guided techniques. As procedure volumes increase, healthcare providers are investing in mobile and fixed fluoroscopy systems capable of supporting diverse interventions while maintaining image quality and radiation dose management. The expanding use of ambulatory surgical centres is strengthening demand for compact and mobile imaging equipment.

These facilities often require flexible systems that can support multiple procedures without extensive infrastructure modifications. Technological improvements in flat-panel detectors, digital imaging, dose reduction, and image processing are making fluoroscopy systems increasingly suitable for modern minimally invasive workflows. Aging populations and the increasing prevalence of orthopedic and cardiovascular conditions are also contributing to procedure volumes requiring intraoperative imaging.

Restraint - Shortage of Trained Intraoperative Imaging Personnel

A shortage of trained personnel capable of operating fluoroscopy and C-arm systems can constrain market expansion, particularly in hospitals and surgical facilities with limited technical resources. These systems require operators to understand imaging parameters, positioning, radiation safety, dose management, and procedure-specific requirements. Inadequate training can affect workflow efficiency and increase the risk of unnecessary radiation exposure for patients and healthcare workers.

The growing sophistication of modern C-arms is increasing the importance of specialized training. Systems incorporating advanced image processing, three-dimensional imaging, navigation capabilities, and automated dose-management functions may require additional technical knowledge. Healthcare providers must therefore invest in structured training, certification, and continuing education to ensure safe and effective equipment use. Manufacturers are responding through application training, remote support, user education, and simplified operating interfaces, but skill gaps remain a challenge in resource-constrained settings.

Opportunity - Integration of AI, 3D Imaging, and Dose-Optimization Technologies

Integration of artificial intelligence, three-dimensional imaging, and automated dose-optimization technologies presents a significant opportunity for the Fluoroscopy and C-Arms market. AI-enabled image processing can support clearer visualization, noise reduction, anatomical recognition, and workflow assistance while helping clinicians interpret procedural images more efficiently. Three-dimensional imaging capabilities can provide improved anatomical visualization during complex orthopedic, vascular, and interventional procedures.

Advanced systems can also combine multiple imaging functions within a single platform, reducing the need for equipment transfers and improving operating-room efficiency. These capabilities create opportunities for manufacturers to differentiate products through smarter, more connected, and clinically focused imaging solutions. Radiation dose management represents another important area for technological development because fluoroscopy procedures can involve prolonged imaging exposure.

Modern systems increasingly incorporate automated exposure controls, real-time dose monitoring, image enhancement, and software-based optimization to maintain diagnostic or procedural image quality while minimizing radiation. Combining these capabilities with AI could enable systems to automatically adjust imaging parameters according to procedural requirements and patient characteristics. Integration with surgical navigation, robotic platforms, hospital information systems, and digital operating rooms could expand the role of C-arms beyond conventional imaging.

Product Type Insights

Mobile C-arms are expected to lead accounting for 52% of revenue in 2026, due to their portability, flexible operating-room deployment, and broad use across orthopedic, trauma, cardiovascular, and pain-management procedures. Their ability to serve multiple surgical rooms without extensive fixed infrastructure makes them attractive to hospitals and ambulatory surgical centers. For example, Ziehm Imaging’s Ziehm Vision RFD supports orthopedic, trauma, cardiovascular, and vascular procedures with advanced mobile imaging capabilities.

Mini size C-arms are likely to represent the fastest-growing segment, supported by increasing demand for compact imaging systems in extremity surgery, outpatient orthopedics, and specialized surgical settings. Their smaller footprint enables convenient positioning around the operating table while providing immediate visualization during procedures involving the hand, wrist, foot, and ankle. Growing migration toward outpatient procedures is creating additional demand for space-efficient imaging equipment. For instance, OrthoScan’s mini C-arm systems are specifically designed for extremity imaging and orthopedic procedures, supporting efficient intraoperative visualization.

Application Insights

Angiography is projected to lead the market, capturing around 46% of the revenue share in 2026, supported by its extensive use in cardiovascular and vascular interventions that require continuous, real-time visualization. Increasing adoption of minimally invasive cardiovascular procedures is encouraging healthcare facilities to invest in advanced fluoroscopy systems offering high image quality, dose optimization, and workflow integration. These capabilities support accurate catheter positioning and treatment during complex interventions. A notable example includes Philips Azurion image-guided therapy systems, which are designed to support cardiac and vascular procedures with integrated imaging and workflow technologies.

Image-guided biopsy is likely to be the fastest-growing packaging type due to increasing preference for minimally invasive tissue sampling and precise targeting of suspicious lesions. Real-time imaging helps clinicians guide instruments accurately while reducing unnecessary tissue disruption, making these systems valuable across oncology and interventional procedures. Improvements in image quality, workflow automation, and dose management are supporting adoption. For instance, Hologic’s Brevera Breast Biopsy System combines tissue acquisition with real-time imaging and specimen verification to streamline breast biopsy procedures.

North America Fluoroscopy and C - Arms Market Trends

North America is anticipated to be the leading region, accounting for a market share of 38% in 2026, supported by advanced hospital infrastructure, high volumes of orthopedic and cardiovascular procedures, and increasing adoption of mobile imaging platforms. Demand is shifting toward flat-panel detectors, low-dose imaging, 3D visualization, and equipment designed for ambulatory surgical centers. Replacement of aging imaging fleets and expansion of minimally invasive procedures are also supporting purchases.

U.S. Fluoroscopy and C - Arms Market Trends

The U.S. is expected to dominate the regional market, accounting for approximately 80% of the North America market share in 2026, driven by strong adoption of mobile C-arms across orthopedic and minimally invasive procedures.  Hospitals and ASCs are increasingly seeking compact systems with advanced imaging and dose-management capabilities. In November 2025, Shimadzu Medical Systems USA launched the SC15 mobile C-arm in the U.S., featuring flat-panel detector technology and enhanced workflow features. The country also continues to see investment in advanced surgical imaging technologies.

Canada Fluoroscopy and C - Arms Market Trends

Canada is likely to be a significant market for fluoroscopy and C - arms holds approximately 20% of the North America market share in 2026, supported by increasing adoption of advanced imaging technologies across diagnostic and interventional care. Academic and hospital centers are advancing AI and other imaging innovations. A 2025 review highlighted the growing use of advanced imaging technologies and AI across Canadian radiology centers. These developments support demand for modern fluoroscopy and C-arm equipment. 

Europe Fluoroscopy and C - Arms Market Trends

Europe is likely to be a significant market for fluoroscopy and C - arms in 2026. Hospitals are increasingly adopting mobile systems, digital flat-panel detectors, advanced image processing, and dose-optimization technologies. Regulatory attention toward radiation exposure is also encouraging healthcare providers to upgrade equipment with improved dose-management capabilities. For example, in 2025, the U.K. introduced updated National Diagnostic Reference Levels covering radiography and fluoroscopy, reinforcing the region’s focus on optimizing medical radiation exposure.

U.K. Fluoroscopy and C - Arms Market Trends

The U.K. is likely to be a significant market for fluoroscopy and C - arms estimates for 15% of Europe market share in 2026, supported by NHS modernization and increasing attention to radiation-dose optimization. The UKHSA published its latest national survey of radiographic and fluoroscopic patient doses in July 2025. The survey included data from 239 fluoroscopy systems across hospitals. Such national benchmarking supports adoption of safer and more efficient fluoroscopy equipment.

Germany Fluoroscopy and C - Arms Market Trends

Germany is anticipated to dominate the regional market, accounting for around 37% of the Europe market share in 2026. Germany has a strong base of advanced medical technology manufacturers and sophisticated hospital infrastructure. Demand is supported by orthopedic, cardiovascular, and interventional procedures requiring real-time imaging. Hospitals are increasingly focusing on digital imaging, workflow efficiency, and radiation-dose optimization. The country also benefits from strong domestic expertise in medical imaging technology.

Asia Pacific Fluoroscopy and C - Arms Market Trends

The Asia Pacific region is likely to be the fastest-growing region during the forecast period. Its healthcare infrastructure development, increasing surgical volumes, growing medical technology adoption, and rising demand for minimally invasive procedures. China and India are becoming important markets as hospitals expand imaging capacity and manufacturers strengthen local production and distribution networks. Demand is particularly strong for mobile and cost-efficient systems that can serve orthopedic, trauma, cardiovascular, and general surgical applications.

China Fluoroscopy and C - Arms Market Trends

China is projected to dominate the regional market, holding around 30% share of the Asia Pacific market in 2026. China is expanding hospital capacity and investing in advanced diagnostic and surgical imaging technologies. Large tertiary hospitals remain important purchasers of sophisticated fluoroscopy and C-arm systems. Demand is supported by increasing orthopedic, cardiovascular, and minimally invasive procedures. Domestic manufacturing capabilities are also strengthening the availability of cost-competitive imaging equipment.

India Fluoroscopy and C - Arms Market Trends

India is expected to emerge as a significant market, accounting for approximately 22% of the Asia Pacific market share in 2026, driven by rising demand for mobile C-arms as hospitals and surgical centers increasingly adopt minimally invasive procedures. Growth is further supported by rising private healthcare investments and the modernization of operating rooms. Wipro GE HealthCare, a joint venture involving GE HealthCare, also manufactures C-arm systems in India.

The global fluoroscopy and C - arms market exhibits a moderately fragmented structure, driven by strong competition among established medical imaging companies, specialized C-arm manufacturers, and regional technology providers. Companies are increasingly differentiating their offerings through 3D imaging, improved workflow automation, and compact systems designed for orthopedic and minimally invasive procedures.

With key leaders, including Ziehm Imaging GmbH, GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., Hologic, Canon Medical Systems, and Shimadzu, the market combines broad multinational portfolios with specialized mobile imaging expertise. These players compete through product innovation, image-quality improvements, radiation-dose optimization, mobile system development, software integration, and expanded service networks.

Key Industry Developments:

• In November 2025, Shimadzu Medical Systems USA announced the U.S. release of the SC15 mobile C-arm, featuring flat-panel detector technology, advanced fluoroscopic imaging, dose-management controls, auto-collimation, and an optional vascular package for applications including orthopedics, pain management, general surgery, and vascular procedures.